Drugs Made In America Acquisition II Corp

DMII

Capitalización de mercado USD 648 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Karpus Investment Management Pittsford, New York	USD 28 M	+USD 1.91 M	+190,075	+7%
2	2 Magnetar Financial Evanston, Illinois	USD 27.2 M	–	–	–
3	MI 3 MMCAP International Grand Cayman, Cayman Islands	USD 27.2 M	–	–	–
4	4 Glazer Capital LLC New York	USD 23.6 M	-USD 65.1 k	-6,483	-0.3%
5	5 Highbridge Capital Management New York	USD 22.6 M	+USD 20.2 M	+2,016,211	+896%
6	6 Millennium Management New York	USD 20.1 M	+USD 172 k	+17,133	+0.9%
7	7 Hudson Bay Capital Management Stamford, Connecticut	USD 19.8 M	–	–	–
8	8 Wolverine Asset Management Chicago, Illinois	USD 18.7 M	+USD 602 k	+59,931	+3%
9	9 Polar Asset Management Partners Toronto, Ontario, Canada	USD 15.1 M	–	–	–
10	10 Tenor Capital Management New York	USD 15.1 M	–	–	–
11	11 D.E. Shaw & Co New York	USD 14.8 M	+USD 852 k	+84,900	+6%
12	12 AQR Arbitrage Greenwich, Connecticut	USD 11.4 M	+USD 189 k	+18,876	+2%
13	13 Aristeia Capital Greenwich, Connecticut	USD 11.1 M	–	–	–
14	CA 14 Crossingbridge Advisors Pleasantville, New York	USD 11.1 M	+USD 7.53 M	+750,000	+214%
15	15 First Trust Capital Management Chicago, Illinois	USD 10.7 M	–	–	–
16	16 Davidson Kempner Capital Management New York	USD 10.1 M	–	–	–
17	17 OMERS Administration Corp Toronto, Ontario, Canada	USD 10.1 M	–	–	–
18	18 Picton Mahoney Asset Management Toronto, Ontario, Canada	USD 8.93 M	+USD 130 k	+13,000	+1%
19	19 Two Sigma Investments New York	USD 8.92 M	–	–	–
20	20 Context Capital Management Lajolla, California	USD 7.54 M	–	–	–
21	21 Ghisallo Capital Management Boston, Massachusetts	USD 7.54 M	–	–	–
22	MCS 22 Mercuria Capital Strategies Houston, Texas	USD 7.54 M	–	–	–
23	23 Moore Capital Management New York	USD 7.54 M	–	–	–
24	24 Westchester Capital Management (New York) Valhalla, New York	USD 6.26 M	+USD 1.22 M	+121,791	+24%
25	25 Radcliffe Capital Management Bala Cynwyd, Pennsylvania	USD 5.79 M	–	–	–

Drugs Made In America Acquisition II Corp DMII Capitalización de mercado USD 648 M

Drugs Made In America Acquisition II Corp

DMII

Capitalización de mercado USD 648 M